Clinical trial
Study of Urate Elevation in Parkinson's Disease, Phase 3
NCT02642393
Study timeline
Study start (actual)2016-06-01Date precision: month
Registry last updated2020-07-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson's Diseaseunresolved
Interventions
Sponsors & collaborators
Michael Alan Schwarzschildlead sponsor
The Parkinson Study Groupcollaborator
University of Rochestercollaborator
Mapped research locations
BostonMassachusetts, United States3HoustonTexas, United States2ChicagoIllinois, United States2BaltimoreMaryland, United States2ClevelandOhio, United States2SpokaneWashington, United States2New YorkNew York, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02642393 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.